Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 4Breast 3Gastrointestinal 2Sarcoma 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Fitness Trackers × Tumor-Agnostic × Clear all
NCT03971266 2025-09-02

Movement and Fitness Trackers in Determining Performance Status

University of Southern California

Phase NA Terminated
31 enrolled
Tumor-Agnostic

Neoplasms

NCT03757182 2024-08-27

DigiSTEPS

Cedars-Sinai Medical Center

Active not recruiting
80 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02779725 2023-11-08

SCH

University of Utah

Phase NA Completed
884 enrolled
Tumor-Agnostic

Neoplasms

NCT02659358 2017-09-25

Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer

Cedars-Sinai Medical Center

Completed
37 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡